Wednesday, March 1, 2023: D.C. News

Federal health advisers narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV. The Food and Drug Administration panel voted 7-4 on two separate questions of...

Tuesday, February 28, 2023: Payers

A new study found that Medicare Advantage (MA) had fewer avoidable hospitalizations for acute conditions compared to traditional Medicare, a trend that may be caused by shifting patients to other sites of care. The study, published in the Journal of the American...